Commentary

Commentary

rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies

April 26, 2023

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.

Commentary

The Emerging Treatment Landscape in Schizophrenia

January 18, 2023

This article provides an overview of emerging therapies poised to transform the treatment paradigm for patients with living with schizophrenia.

Commentary

Schizophrenia: Salient Symptoms and Pathophysiology

January 18, 2023

This article notes the distinction between positive and negative schizophrenic symptoms and provides an updated overview of disease pathophysiology.

Commentary

Adverse Events and Treatment Adherence in Schizophrenia

January 18, 2023

This article examines the effects of treatment-related adverse events on adherence to medication and strategies to improve adherence in practice.

Commentary

The Epidemiology and Global Burden of Schizophrenia

January 18, 2023

This article explores the costs and burden of schizophrenia and provides an overview of disease prevalence, incidence, and trends over time.

Commentary

Optimizing Therapy Selection, Sequencing in Schizophrenia

January 18, 2023

This article summarizes the current treatment landscape in schizophrenia, along with contexts in which agents should be prescribed.